Submitted by admin on Fri, 2025-04-25 13:24

Tepezza

  • Brand name/Generic name: Tepezza/teprotumamab-trbw
  • How Administered at HOA: intravenous infusion
  • Duration of Treatment: 90 minutes for the first two infusions and 60 minutes thereafter
  • Frequency of Treatment: every three weeks for eight infusions
  • Conditions this Medication Treats: Thyroid eye disease (TED)
  • Link for more Information: https://www.tepezza.com/
Submitted by admin on Fri, 2025-04-25 13:24

Stelara

  • Brand name/Generic name: Stelara/ustekinumab
  • How Administered at HOA: intravenous induction followed by subcutaneous injection maintenance
  • Duration of Treatment: 60 minutes (intravenous)/fast subcutaneous injection
  • Frequency of Treatment: varies depending on indication
  • Conditions this Medication Treats:
    • Crohn disease
    • ulcerative colitis
    • plaque psoriasis
    • psoriatic arthritis
Submitted by admin on Fri, 2025-04-25 13:24

Soliris

  • Brand name/Generic name: Soliris/eculizumab
  • How Administered at HOA: intravenous infusion
  • Duration of Treatment: thirty five minutes
  • Frequency of Treatment: once per week for the first 5 weeks and once every 2 weeks thereafter
  • Conditions this Medication Treats: anti-aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD), paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome, myasthenia gravis
Submitted by admin on Fri, 2025-04-25 13:23

Skyrizi

  • Brand name/Generic name: Skyrizi/risankizumab-rzaa
  • How Administered at HOA:
    • subcutaneous injection for psoriasis and ulcerative colitis
    • intravenous infusion for Crohn’s disease
  • Duration of Treatment:
    • one hour for Crohn’s disease
    • two hours for ulcerative colitis
  • Frequency of Treatment: every four weeks
  • Conditions this Medication Treats:
    • Plaque psoriasis
    • Psoriatic arthritis
Submitted by admin on Fri, 2025-04-25 13:23

Rituxan

  • Brand name/Generic name: Rituxan/rituximab
  • How Administered at HOA: intravenous infusion
  • Duration of Treatment: after first dose between three to four hours
  • Frequency of Treatment: varies based on indication
  • Conditions this Medication Treats:
    • rheumatoid arthritis
    • Granulomatosis with Polyangiitis (GPA)
    • Pemphigus Vulgaris (PV)
Submitted by admin on Fri, 2025-04-25 13:23

Remicade

  • Brand name/Generic name: Remicade/infliximab
  • How Administered at HOA: intravenous infusion
  • Duration of Treatment: approximately two hours
  • Frequency of Treatment: every eight weeks (after initial doses)
  • Conditions this Medication Treats: Crohn disease, ulcerative colitis, plaque psoriasis, psoriatic arthritis
  • Link for more Information: https://www.remicade.com/index.html
Submitted by admin on Fri, 2025-04-25 13:23

Prolia

  • Brand name/Generic name: Prolia/denosumab
  • How Administered at HOA: subcutaneous injection
  • Duration of Treatment: fast subcutaneous injection
  • Frequency of Treatment: every six months
  • Conditions this Medication Treats: postmenopausal osteoporosis
  • Link for more Information: https://www.prolia.com/postmenopausal-osteoporosis/dosing
Submitted by admin on Fri, 2025-04-25 13:23

Prolastin

  • Brand name/Generic name: Prolastin/ Alpha1-Proteinase Inhibitor (human)
  • How Administered at HOA: intravenous infusion
  • Duration of Treatment: 15 to 30 minutes
  • Frequency of Treatment: weekly
  • Conditions this Medication Treats: emphysema due to alpha1-antitrypsin deficiency
  • Link for more Information: https://www.drugs.com/prolastin-c.html
Submitted by admin on Fri, 2025-04-25 13:22

Onpattro

  • Brand name/Generic name: Onpattro/patisiran
  • How Administered at HOA: intravenous infusion
  • Duration of Treatment: 80 minutes
  • Frequency of Treatment: every three weeks
  • Conditions this Medication Treats: polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR)
  • Link for more Information: https://www.onpattro.com/
Submitted by admin on Fri, 2025-04-25 13:22

Omvoh

  • Brand name/Generic name: Omvoh/ mirikizumab-mrkz
  • How Administered at HOA: intravenous infusion
  • Duration of Treatment: 30 to 90 minutes based on dose
  • Frequency of Treatment: every four weeks
  • Conditions this Medication Treats: moderately to severely active ulcerative colitis, Crohn’s disease
  • Link for more Information: https://www.drugs.com/omvoh.html

Pages